Analyst Ratings for Pentair
Within the last quarter, Pentair (NYSE:PNR) has observed the following analyst ratings:
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Cowen & Co. Maintains Outperform on Pentair, Lowers Price Target to $75
Cowen & Co. analyst Joseph Giordano maintains Pentair (NYSE:PNR) with a Outperform and lowers the price target from $85 to $75.
Pentair’s Return On Capital Employed Overview
Pulled from Benzinga Pro data, Pentair (NYSE:PNR) showed a loss in earnings since Q4, totaling $117.60 million. Sales, on the other hand, increased by 1.11% to $999.60 million during Q1.
RBC Capital Maintains Sector Perform on Pentair, Raises Price Target to $58
RBC Capital analyst Deane Dray maintains Pentair (NYSE:PNR) with a Sector Perform and raises the price target from $57 to $58.
Pentair’s Earnings Outlook
Pentair (NYSE:PNR) is set to give its latest quarterly earnings report on Thursday, 2022-04-21. Here's what investors need to know before the announcement.
Analysts estimate that Pentair will report an earnings per share (EPS) of $0.81.
Lennox Names Alok Maskara As CEO; Reiterates FY22 Outlook
Lennox International Inc. (NYSE:LII) has appointed Alok Maskara as its CEO, effective on May 9, 2022. Maskara succeeds Todd Bluedorn, who…
Merger Arbitrage Mondays – Healthcare Trust Of America To Combine With Healthcare Realty Trust
Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced were potential deals in the works.
Healthcare Trust of America (NYSE: HTA)
Analyst Ratings For Pentair
Within the last quarter, Pentair (NYSE:PNR) has observed the following analyst ratings: